X0609 4 2026-10-14 0 0001388320 Actinium Pharmaceuticals, Inc. ATNM 0001811612 David Matthew T false 100 PARK AVENUE, 23RD FLOOR NEW YORK NY 10017 0 1 0 0 Chief Financial Officer 0 Common Stock 2026-10-14 4 A 0 250000 0 A 250000 D Stock Option (right to purchase) 0.9750 2026-10-14 4 A 0 250000 0 A 2036-10-14 Common Stock 250000 250000 D On October 14, 2026 (the "Grant Date"), Mr. David was granted two hundred fifty thousand (250,000) Restricted Stock Units ("RSUs") under the Actinium Pharmaceuticals, Inc. 2026 Employment Inducement Award Plan (the "Inducement Plan"). One hundred twenty-five thousand (125,000) RSUs shall vest in three (3) equal installments on each of the first, second, and third anniversaries of the Grant Date, subject to Mr. David's continuing service to the Issuer on each the applicable vesting date. One hundred twenty-five thousand (125,000) RSUs shall vest in full on the third (3rd) anniversary of the Grant Date, subject to Mr. David's continuing service to the Issuer on the applicable vesting date. On the Grant Date, Mr. David was granted the option to purchase 250,000 shares of common stock (the "Option Grant") of Actinium Pharmaceuticals, Inc. (the "Issuer") under the Inducement Plan. Twenty-eight percent (28%) of the Option Grant shall vest twelve (12) months after the Grant Date and two percent (2%) of the Option Grant shall vest each month thereafter, subject to Mr. David's continuing service to the Issuer on each application vesting date. /s/ Matthew T David 2026-10-16